Concepedia

Publication | Closed Access

Diabetes mellitus reduces the therapeutic effectiveness of interferon‐α2b plus ribavirin therapy in patients with chronic hepatitis C

DOI

30

Citations

38

References

2007

Year

Ichiro Konishi, Norio Horiike, Yoichi Hiasa, Yoshio Tokumoto, Toshie Mashiba, Kojiro Michitaka, Y. Miyake, Suguru Nonaka, Kouji Joukou, Bunzo Matsuura,
Hepatology Research

Abstract

The findings indicate that DM reduces the response to IFN-alpha2b plus ribavirin therapy in CHC patients.

References

YearCitations

Page 1